EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Incidence and Management Trends in Advanced Head and Neck Non-Melanoma Skin Cancer in Ontario

Ka-Kit David Yeung iD, Gregory Pond iD, Isaac Kong iD, Han Zhang, Michael Gupta, Zejia Chen, Justin Lee

Current Oncology · 17.05.2026 · 33 (5) · 291

DOI: 10.3390/curroncol33050291 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Oncology, online erschienen am 17.05.2026. Verfasst von Ka-Kit David Yeung und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Radiation Oncology, Department of Oncology, Faculty of Health Sciences, McMaster University, Hamilton, ON L8S 4L8, Canada. Hauptthemen laut MEDLINE: Non-Melanoma Skin Neoplasms, Head and Neck Neoplasms. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Juravinski Hospital and Cancer Centre Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Head and neck non-melanoma skin cancers (H&N NMSCs) account for most head and neck malignancies. While primary treatment comprises surgery, adjuvant radiation is recommended in advanced tumors. Radiation oncology practice patterns for resected locally advanced (rLA) and locoregional (rLR) H&N NMSCs have not been well characterized. Using data from the Institute for Clinical Evaluative Sciences (ICES) between 2003 and 2019, we conducted a longitudinal, population-based study characterizing disease incidence, survival outcomes, and radiation utilization patterns. Among 2962 rLA and 1055 rLR cases, rLA incidence rose more than tenfold compared to population growth; however rLR incidence remained stable. Radiation oncology consultations occurred in 29.6% of rLA and 50.7% of rLR patients. Increased age, multiple cancers at diagnosis, non-rural demographic, and higher SES were observed to be correlated to receipt of adjuvant radiation treatment. Only 19.4% of rLA and 37.95 of rLR disease received adjuvant RT, which is much lower than expected based on international guidelines. Five-year overall survival (OS) was 69% (95% confidence interval (CI): 67–71%) for rLA and 68% (95% CI: 65–71%) for rLR disease. These findings highlight the burden of advanced H&N NMSC, low rates of radiation utilization and the need for improving referral pathways and guideline adherence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-Melanoma Skin NeoplasmsHead and Neck NeoplasmsHumansIncidenceOntarioFemaleMaleAgedMiddle AgedAged, 80 and overAdult

Stichwörter der Autor:innen

CanadaOntarioadjuvant radiationadjuvant treatmenthead and neck cancernon-melanoma skin cancerpopulation-based studyradiation oncology

Autor:innen und Institutionen

  • Division of Radiation Oncology, Department of Oncology, Faculty of Health Sciences, McMaster University, Hamilton, ON L8S 4L8, Canada.
  • Division of Otolaryngology, Department of Surgery, Faculty of Health Sciences, McMaster University, Hamilton, ON L8S 4L8, Canada.
  • Faculty of Medicine, Queen's University, Kingston, ON K7L 3N6, Canada.

ORCID-Profile: Ka-Kit David Yeung, Gregory Pond, Isaac Kong

Förderung

  • Juravinski Hospital and Cancer Centre Foundation

Zitieren

APA

Yeung, K. D., Pond, G., Kong, I., Zhang, H., Gupta, M., Chen, Z., & Lee, J. (2026). Incidence and Management Trends in Advanced Head and Neck Non-Melanoma Skin Cancer in Ontario. Current Oncology, 33(5), 291. https://doi.org/10.3390/curroncol33050291

Vancouver

Yeung KD, Pond G, Kong I, Zhang H, Gupta M, Chen Z, et al. Incidence and Management Trends in Advanced Head and Neck Non-Melanoma Skin Cancer in Ontario. Current Oncology. 2026;33(5):291. doi:10.3390/curroncol33050291

BibTeX
@article{Yeung2026,
  author = {Yeung, Ka-Kit David and Pond, Gregory and Kong, Isaac and Zhang, Han and Gupta, Michael and Chen, Zejia and Lee, Justin},
  title = {Incidence and Management Trends in Advanced Head and Neck Non-Melanoma Skin Cancer in Ontario},
  journal = {Current Oncology},
  year = {2026},
  volume = {33},
  number = {5},
  pages = {291},
  doi = {10.3390/curroncol33050291}
}
Kostenlos starten →